Streetbeat News

Earnings

CRON

Cronos Group reported Q4 2023 adjusted EPS of $(0.19), missing the $(0.02) estimate, with sales of $23.91M also missing the $25.31M estimate. This represents a 4.49% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:11 pm

COMM

CommScope Holding Co's shares dropped following the announcement of their Q4 financial results, which fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:11 pm

TCNNF

Trulieve Cannabis Corp. (OTCQX:TCNNF) reported Q4 revenue of $287 million, surpassing estimates and showing an increase from the previous quarter. Adjusted EPS was $0.12, beating estimates. However, the company reported a higher net loss for the full year, with a net loss of $527 million compared to $246 million in 2022. CEO Kim Rivers highlighted the company's focus on cash generation and investments for future growth. Trulieve ended 2023 with $208 million in cash and operates 193 retail dispensaries in the US.

Portfolio Pulse from Nina Zdinjak

February 29, 2024 | 1:10 pm

CRAI

CRA International projects its FY24 revenue to be in the range of $645M-$675M, surpassing the estimated $630.81M.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:10 pm

VCEL

Vericel projects its 2024 revenue to be between $237M and $241M, closely aligning with the consensus estimate of $240.24M. The company also anticipates a gross margin of around 70% and an adjusted EBITDA margin of about 20%.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:08 pm

GECC

Great Elm Capital (NASDAQ:GECC) reported Q4 sales of $9.16M, surpassing the $9.13M estimate, marking a 25.08% increase from the previous year's $7.33M.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:08 pm

CRAI

CRA International (CRAI) reported Q4 adjusted EPS of $1.63, surpassing the $1.10 estimate, and sales of $161.61M, exceeding the $149.67M estimate. This represents an 18.98% increase in EPS and an 11.48% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:08 pm

DUOL

FIGS

VCSA

VLCN

WW

In Thursday's pre-market session, 12 consumer discretionary stocks showed significant movement. Volcon, J-Long Group, and Bright Scholar Education were among the top gainers, with Volcon leading at a 79.3% increase. Duolingo also saw a notable rise after its Q4 earnings release. On the downside, Vacasa, WW International, and FIGS experienced significant drops, with their recent Q4 earnings impacting their stock prices.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 1:07 pm

TCPC

BlackRock TCP Capital Corp. reported a Net Investment Income (NII) of $0.44, compared to $0.34 year-over-year (YoY), indicating a significant increase in profitability.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:07 pm

BFLY

ENVB

IRWD

In Thursday's pre-market session, several healthcare stocks showed significant movement. Enveric Biosciences, Societal CDMO, and NeuroBo Pharmaceuticals were among the top gainers, with Enveric Biosciences leading at a 162.3% increase. On the losing side, Ironwood Pharmaceuticals, Milestone Pharmaceuticals, and Butterfly Network saw notable declines, with Ironwood Pharmaceuticals dropping by 27.7%. Earnings releases influenced some of the stock movements.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 1:07 pm